Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karthik Lingineni

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Combinatorial Chemistry & High Throughput Screening|May 26, 2015
Classification of Breast Cancer Resistant Protein (BCRP) Inhibitors and Non-Inhibitors Using Machine Learning ApproachesVilas Belekar, Karthik Lingineni, Prabha Garg
Molecular Diversity|January 5, 2017
The role of multidrug resistance protein (MRP-1) as an active efflux transporter on blood-brain barrier (BBB) permeabilityKarthik Lingineni, Vilas Belekar, Sujit R Tangadpalliwar, et al.
Clinical and Translational Science|February 14, 2020
Predicting Cost-Effectiveness of Generic vs. Brand Dabigatran Using Pharmacometric Estimates Among Patients with Atrial Fibrillation in the United StatesChing-Yu Wang, Phuong N Pham, Sarah Kim, et al.
Clinical Pharmacology and Therapeutics|October 21, 2021
Determining the Exposure Threshold for Levonorgestrel Efficacy Using an Integrated Model Based Meta-Analysis ApproachKarthik Lingineni, Ayyappa Chaturvedula, Brian Cicali, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 20, 2020
Quantitative Assessment of Levonorgestrel Binding Partner Interplay and Drug-Drug Interactions Using Physiologically Based Pharmacokinetic ModelingBrian Cicali, Karthik Lingineni, Rodrigo Cristofoletti, et al.
Journal of Clinical Pharmacology|September 8, 2020
Development and Verification of a Body Weight-Directed Disease Trial Model for Glucose HomeostasisNashid Farhan, Ines Gebert, Yifan Xing, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 17, 2024
Development of breakthrough bleeding model of combined-oral contraceptives utilizing model-based meta-analysisHuili Chen, Dain Chun, Karthik Lingineni, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 15, 2021
Physiologically-based pharmacokinetics modeling to investigate formulation factors influencing the generic substitution of dabigatran etexilateNashid Farhan, Rodrigo Cristofoletti, Sumit Basu, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 8, 2021
Development of a model-based clinical trial simulation platform to optimize the design of clinical trials for Duchenne muscular dystrophyKarthik Lingineni, Varun Aggarwal, Juan Francisco Morales, et al.
Clinical Pharmacology and Therapeutics|October 19, 2020
Quantitative Benefit-Risk Assessment of P-gp-Mediated Drug-Drug Interactions of Dabigatran Coadministered With Pharmacokinetic Enhancers in Patients With Renal ImpairmentKarthik Lingineni, Nashid Farhan, Sarah Kim, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Combinatorial Chemistry & High Throughput Screening|May 26, 2015
Classification of Breast Cancer Resistant Protein (BCRP) Inhibitors and Non-Inhibitors Using Machine Learning ApproachesVilas Belekar, Karthik Lingineni, Prabha Garg
Molecular Diversity|January 5, 2017
The role of multidrug resistance protein (MRP-1) as an active efflux transporter on blood-brain barrier (BBB) permeabilityKarthik Lingineni, Vilas Belekar, Sujit R Tangadpalliwar, et al.
Clinical and Translational Science|February 14, 2020
Predicting Cost-Effectiveness of Generic vs. Brand Dabigatran Using Pharmacometric Estimates Among Patients with Atrial Fibrillation in the United StatesChing-Yu Wang, Phuong N Pham, Sarah Kim, et al.
Clinical Pharmacology and Therapeutics|October 21, 2021
Determining the Exposure Threshold for Levonorgestrel Efficacy Using an Integrated Model Based Meta-Analysis ApproachKarthik Lingineni, Ayyappa Chaturvedula, Brian Cicali, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 20, 2020
Quantitative Assessment of Levonorgestrel Binding Partner Interplay and Drug-Drug Interactions Using Physiologically Based Pharmacokinetic ModelingBrian Cicali, Karthik Lingineni, Rodrigo Cristofoletti, et al.
Journal of Clinical Pharmacology|September 8, 2020
Development and Verification of a Body Weight-Directed Disease Trial Model for Glucose HomeostasisNashid Farhan, Ines Gebert, Yifan Xing, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 17, 2024
Development of breakthrough bleeding model of combined-oral contraceptives utilizing model-based meta-analysisHuili Chen, Dain Chun, Karthik Lingineni, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 15, 2021
Physiologically-based pharmacokinetics modeling to investigate formulation factors influencing the generic substitution of dabigatran etexilateNashid Farhan, Rodrigo Cristofoletti, Sumit Basu, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 8, 2021
Development of a model-based clinical trial simulation platform to optimize the design of clinical trials for Duchenne muscular dystrophyKarthik Lingineni, Varun Aggarwal, Juan Francisco Morales, et al.
Clinical Pharmacology and Therapeutics|October 19, 2020
Quantitative Benefit-Risk Assessment of P-gp-Mediated Drug-Drug Interactions of Dabigatran Coadministered With Pharmacokinetic Enhancers in Patients With Renal ImpairmentKarthik Lingineni, Nashid Farhan, Sarah Kim, et al.
Pageof 2